Biodesix
BDSX
37 hedge funds and large institutions have $30.7M invested in Biodesix in 2023 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 6 increasing their positions, 11 reducing their positions, and 3 closing their positions.
300% more call options, than puts
Call options by funds: $4K | Put options by funds: $1K
267% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 3
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
48% more capital invested
Capital invested by funds: $20.7M → $30.7M (+$10M)
28% more funds holding
Funds holding: 29 → 37 (+8)
0.03% more ownership
Funds ownership: 1.07% → 1.1% (+0.03%)
45% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 11
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
OM
Opaleye Management
Boston,
Massachusetts
|
+$632K |
| 2 |
BC
Birchview Capital
Burlington,
Vermont
|
+$428K |
| 3 |
CAN
Cetera Advisor Networks
El Segundo,
California
|
+$108K |
| 4 |
HF
HRT Financial
New York
|
+$86.8K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$61.9K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
-$376K |
| 2 |
ACM
AIGH Capital Management
Baltimore,
Maryland
|
-$215K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
-$127K |
| 4 |
WVP
Worth Venture Partners
Fort Lee,
New Jersey
|
-$84.9K |
| 5 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$69.4K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
Prudential Financial
Newark,
New Jersey
| $40.9K | +$34.4K | +1,240 | New |
|
27
Renaissance Technologies
New York
| $35K | -$17.6K | -635 | -37% |
|
28
Charles Schwab
San Francisco,
California
| $34K | – | – | – |
|
29
Corient Private Wealth
Miami,
Florida
| $25.6K | – | – | – |
|
30
CIBC Private Wealth Group
Atlanta,
Georgia
| $21.6K | – | – | – |
|
31
Morgan Stanley
New York
| $17.6K | -$11.7K | -422 | -44% |
|
32
Qube Research & Technologies (QRT)
London,
United Kingdom
| $10.5K | +$8.83K | +318 | New |
|
|
CCA
33
Column Capital Advisors
Indianapolis,
Indiana
| $9.4K | – | – | – |
|
34
UBS Group
Zurich,
Switzerland
| $4.44K | +$3.53K | +127 | +1,588% |
|
35
Bank of America
Charlotte,
North Carolina
| $2.46K | +$2.08K | +75 | New |
|
36
JP Morgan Chase
New York
| $18 | +$28 | +1 | New |
|
37
Osaic Holdings
Scottsdale,
Arizona
| – | -$1.2K | -49 | Closed |
|
38
Barclays
London,
United Kingdom
| – | -$304 | -12 | Closed |
|
|
GI
39
Gradient Investments
Arden Hills,
Minnesota
| – | -$123 | -5 | Closed |
|
BDSX Hedge Fund Activity: Q3 2023 in Review
37 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in Biodesix (BDSX) for Q3 2023, worth a combined $30.7M — up 48% from $20.7M a quarter earlier.
Buyers outnumbered sellers: 11 funds opened new BDSX positions and 3 closed out — a net gain of 8 holders — while 6 added to existing stakes and 11 trimmed.
The largest buyer was Opaleye Management, opening a new position worth an estimated $632K. The largest seller was Vanguard Group, cutting an estimated $376K.
- 37 institutional investors held Biodesix (BDSX) as of Q3 2023, up from 29 in Q2 2023.
- Funds reported $30.7M of Biodesix stock for Q3 2023, up 48% quarter-over-quarter.
- 11 funds opened new Biodesix positions in Q3 2023 and 3 closed out, a net change of +8 holders.
- The largest Biodesix buyer in Q3 2023 was Opaleye Management, an estimated $632K added.
- The largest Biodesix seller in Q3 2023 was Vanguard Group, an estimated $376K sold.
Based on aggregated 13F filings for Q3 2023.